BRPI0807084A2 - Anticorpos específicos para o virus varicela zoster - Google Patents

Anticorpos específicos para o virus varicela zoster

Info

Publication number
BRPI0807084A2
BRPI0807084A2 BRPI0807084-9A2A BRPI0807084A BRPI0807084A2 BR PI0807084 A2 BRPI0807084 A2 BR PI0807084A2 BR PI0807084 A BRPI0807084 A BR PI0807084A BR PI0807084 A2 BRPI0807084 A2 BR PI0807084A2
Authority
BR
Brazil
Prior art keywords
varus
specific antibodies
varicela
zoster
varicela zoster
Prior art date
Application number
BRPI0807084-9A2A
Other languages
English (en)
Inventor
Roberto Burioni
Massimo Clementi
Original Assignee
Ribovax Biotechnologies Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa filed Critical Ribovax Biotechnologies Sa
Publication of BRPI0807084A2 publication Critical patent/BRPI0807084A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0807084-9A2A 2007-02-06 2008-02-06 Anticorpos específicos para o virus varicela zoster BRPI0807084A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07002478 2007-02-06
PCT/IB2008/000266 WO2008096242A1 (en) 2007-02-06 2008-02-06 Antibodies specific for varicella zoster virus

Publications (1)

Publication Number Publication Date
BRPI0807084A2 true BRPI0807084A2 (pt) 2014-04-29

Family

ID=39523700

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807084-9A2A BRPI0807084A2 (pt) 2007-02-06 2008-02-06 Anticorpos específicos para o virus varicela zoster

Country Status (12)

Country Link
US (1) US20100074906A1 (pt)
EP (1) EP2118139A1 (pt)
JP (1) JP2010517557A (pt)
KR (1) KR20100014921A (pt)
CN (1) CN101663318A (pt)
AU (1) AU2008214476A1 (pt)
BR (1) BRPI0807084A2 (pt)
CA (1) CA2677371A1 (pt)
EA (1) EA200970735A1 (pt)
IL (1) IL200273A0 (pt)
WO (1) WO2008096242A1 (pt)
ZA (1) ZA200906115B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104360055B (zh) * 2014-11-07 2016-05-18 山东泰邦生物制品有限公司 测定水痘-带状疱疹病毒中和抗体的试剂盒及生产使用方法
JP6462791B2 (ja) * 2017-07-25 2019-01-30 田中貴金属工業株式会社 水痘帯状疱疹ウイルス検出用免疫クロマト分析装置
EP3863687A4 (en) 2018-10-09 2022-08-31 Ibex Biosciences, Llc Antibodies directed to filamin-a and therapeutic uses thereof
CN117106070B (zh) * 2019-11-11 2024-06-11 珠海泰诺麦博制药股份有限公司 抗水痘-带状疱疹病毒的抗体
CN114933649B (zh) * 2021-03-10 2023-04-21 北京智仁美博生物科技有限公司 抗水痘-带状疱疹病毒的抗体及其用途
CN116041488B (zh) * 2022-08-19 2024-02-09 成都华任康生物科技有限公司 检测重组水痘-带状疱疹病毒糖蛋白E(gE)的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506132A (en) * 1993-07-28 1996-04-09 Sandoz Pharmaceuticals Corporation Human antibodies against varicella-zoster virus
AR045563A1 (es) * 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf

Also Published As

Publication number Publication date
EA200970735A1 (ru) 2010-02-26
AU2008214476A1 (en) 2008-08-14
EP2118139A1 (en) 2009-11-18
ZA200906115B (en) 2010-06-30
CA2677371A1 (en) 2008-08-14
US20100074906A1 (en) 2010-03-25
IL200273A0 (en) 2010-04-29
CN101663318A (zh) 2010-03-03
JP2010517557A (ja) 2010-05-27
KR20100014921A (ko) 2010-02-11
AU2008214476A2 (en) 2009-10-08
WO2008096242A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
CR10705A (es) Anticuerpos para linfotoxina-alfa
PL3059246T3 (pl) Zmodyfikowany region stały przeciwciała
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
LTC2170959I2 (lt) Antikūnai prieš žmogaus užprogramuotą mirties receptorių PD-1
BRPI0715917A2 (pt) Anticorpos para il-17a
DE602007011793D1 (de) Biaryl-ether-harnstoffverbindungen
BRPI0815075A2 (pt) Aglutinantes
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
DK2131860T3 (da) Anti-sclerostin-antistoffer
PT2195026E (pt) Anticorpos anti-esclerostina
DE112008002590A5 (de) Mikroreaktor
SE0850135L (sv) Häftapparat
BRPI0817427A2 (pt) Anticorpo anti-bst2
EP2186607A4 (en) Stapler
BRPI0818354A2 (pt) vacina preventiva do hiv baseada em anticorpos específicos para o hiv
BRPI0807084A2 (pt) Anticorpos específicos para o virus varicela zoster
BRPI0814716A2 (pt) Comprimidos efervescentes para uso em inalação
ES1065835Y (es) Caperuza para cetreria
ES1063735Y (es) Testero para persiana
DE112007001493A5 (de) Ordnermechanik
ES1065263Y (es) Captafaros para bionda
ES1063779Y (es) Pallon para gaitas
ES1066482Y (es) Pieza constructiva para paramento
ES1065541Y (es) Acoplamiento para pedales

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A, 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.